Structural and functional impact of MProG48Y/ΔP168 mutations in SARS-CoV-2 main protease exhibiting resistance to potent inhibitors
Dipendra Bhandari, Oksana Gerlits, Stephen Keable, Leighton Coates, Annie Aniana, Rodolfo Ghirlando, Nashaat Nashed, Andrey Kovalevsky, John Louis

TL;DR
This study investigates how specific mutations in the SARS-CoV-2 main protease affect its structure, function, and resistance to inhibitors.
Contribution
The study reveals how MProG48Y/ΔP168 mutations alter protease dynamics and reduce inhibitor affinity while maintaining enzymatic activity.
Findings
MProG48Y/ΔP168 retains efficient autoprocessing and catalytic activity similar to the wild type.
The mutant shows a 3- to 5-fold reduced affinity for nirmatrelvir and ensitrelvir but unchanged affinity for GC373.
Structural and dynamic changes in the active site suggest compensatory adjustments in the mutant protease.
Abstract
Mutations in the main protease (MPro) can alter its enzymatic function and influence drug susceptibility, impacting SARS-CoV-2 maturation and propagation. In this study we examine the effects of G48Y and ΔP168 mutation/deletion, located in the substrate-binding subsites S2 and S4, on dimer stability, enzymatic activity, inhibitor binding, and active site dynamics. Despite these mutations, MProG48Y/ΔP168 retains efficient N- terminal autoprocessing and catalytic activity comparable to the wild type (MProWT). Structural analysis reveals an open active site conformation, increased flexibility in the S2 helix, S5 loop, and helical domain, and a ∼40-fold reduction in dimer dissociation constant (Kdimer), despite an 8°C decrease in thermal sensitivity to unfolding. Thermodynamic binding studies indicate a 3-fold and 5-fold reduced affinity for nirmatrelvir and ensitrelvir, respectively, while…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Protease and Inhibitor Mechanisms · interferon and immune responses
